About Product
MOXILON-625 combines the antibacterial strength of amoxycillin with clavulanate protection against beta-lactamase resistance.
It offers broad-spectrum activity against Gram-positive and Gram-negative organisms and supports trusted recovery in clinical infections.
Action
Dual beta-lactam and beta-lactamase inhibition
Clinical Benefit
Broad-spectrum coverage with resistance control
Therapy Advantage
Enhances amoxycillin effectiveness